Birdwatch Archive

Birdwatch Note

2024-10-29 08:47:24 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

コスタイベはベネズエラ馬脳炎ウイルス(VEEV)の要素を含んでおり、VEEVは脳に侵入し、脳炎を起こすので、同様に脳炎を起こす可能性があるというブログの示唆はもっともらしく聞こえます。 しかし、コスタイベが含むVEEVの要素はRNAの複製を行うレプリカーゼのみです(36p)。 https://www.pmda.go.jp/drugs/2023/P20231122002/index.html VEEVが脳に侵入する分子機構は、レプリカーゼとは関係がなく、E1,E2等の様々なVEEVの持つ構造タンパクがかかわっています(下記の論文のintroに要約があります)。 https://www.cell.com/cell-reports/fulltext/S2211-1247(23)00957-9 そのため、上記のような推論は実際にはまるで、分子機構からみて意味を成していない事に注意が必要です。

Written by 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1851091643711275041

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1851184044802998342
  • noteId - 1851184044802998342
  • participantId -
  • noteAuthorParticipantId - 41A6243EF0C5E2F69F5A0D4006A468F4F7CBEC237CAE6ACCC5FB56ED687492FE Participant Details
  • createdAtMillis - 1730191644274
  • tweetId - 1851091643711275041
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 1
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • コスタイベはベネズエラ馬脳炎ウイルス(VEEV)の要素を含んでおり、VEEVは脳に侵入し、脳炎を起こすので、同様に脳炎を起こす可能性があるというブログの示唆はもっともらしく聞こえます。 しかし、コスタイベが含むVEEVの要素はRNAの複製を行うレプリカーゼのみです(36p)。 https://www.pmda.go.jp/drugs/2023/P20231122002/index.html VEEVが脳に侵入する分子機構は、レプリカーゼとは関係がなく、E1,E2等の様々なVEEVの持つ構造タンパクがかかわっています(下記の論文のintroに要約があります)。 https://www.cell.com/cell-reports/fulltext/S2211-1247(23)00957-9 そのため、上記のような推論は実際にはまるで、分子機構からみて意味を成していない事に注意が必要です。

Note Ratings

rated at rated by
2024-10-30 20:00:30 -0500 Rating Details
2024-10-29 11:03:56 -0500 Rating Details
2024-10-29 10:10:22 -0500 Rating Details
2024-10-29 08:20:55 -0500 Rating Details
2024-10-29 06:01:32 -0500 Rating Details
2024-10-29 05:20:30 -0500 Rating Details
2024-10-29 05:16:03 -0500 Rating Details
2024-10-29 04:34:25 -0500 Rating Details
2024-10-29 04:26:32 -0500 Rating Details
2024-10-29 04:09:54 -0500 Rating Details
2024-10-29 04:09:04 -0500 Rating Details
2024-10-29 04:07:54 -0500 Rating Details
2024-10-29 03:56:06 -0500 Rating Details
2024-11-01 13:38:22 -0500 Rating Details
2024-10-30 17:18:10 -0500 Rating Details
2024-10-29 16:03:05 -0500 Rating Details
2024-10-29 11:45:05 -0500 Rating Details
2024-10-29 11:32:06 -0500 Rating Details
2024-10-29 08:38:03 -0500 Rating Details
2024-10-29 07:31:50 -0500 Rating Details
2024-10-29 07:20:06 -0500 Rating Details
2024-10-29 04:34:08 -0500 Rating Details
2024-10-29 04:19:50 -0500 Rating Details
2024-10-29 04:17:29 -0500 Rating Details
2024-10-29 04:17:28 -0500 Rating Details
2024-10-29 04:13:29 -0500 Rating Details
2024-10-29 03:51:55 -0500 Rating Details
2024-10-29 20:39:13 -0500 Rating Details
2024-10-29 20:18:35 -0500 Rating Details
2024-10-29 14:23:01 -0500 Rating Details
2024-10-29 09:09:41 -0500 Rating Details
2024-10-29 08:44:10 -0500 Rating Details
2024-10-29 07:34:56 -0500 Rating Details
2024-10-29 07:19:24 -0500 Rating Details
2024-10-29 06:05:21 -0500 Rating Details
2024-10-29 05:20:15 -0500 Rating Details
2024-10-29 05:14:14 -0500 Rating Details
2024-10-29 04:51:15 -0500 Rating Details
2024-10-29 04:25:23 -0500 Rating Details
2024-10-29 04:24:00 -0500 Rating Details
2024-10-29 04:17:52 -0500 Rating Details
2024-10-29 04:08:27 -0500 Rating Details
2024-10-30 02:15:54 -0500 Rating Details
2024-10-29 17:40:28 -0500 Rating Details
2024-10-29 12:21:14 -0500 Rating Details
2024-10-29 10:06:14 -0500 Rating Details
2024-10-29 09:49:07 -0500 Rating Details
2024-10-29 09:39:05 -0500 Rating Details
2024-10-29 09:15:55 -0500 Rating Details
2024-10-29 06:29:21 -0500 Rating Details
2024-10-29 06:26:47 -0500 Rating Details
2024-10-29 06:25:03 -0500 Rating Details
2024-10-29 06:22:56 -0500 Rating Details
2024-10-29 06:06:41 -0500 Rating Details
2024-10-29 06:02:35 -0500 Rating Details
2024-10-29 05:46:19 -0500 Rating Details
2024-10-29 05:33:20 -0500 Rating Details
2024-10-29 05:10:27 -0500 Rating Details
2024-10-29 04:31:56 -0500 Rating Details
2024-10-29 04:21:41 -0500 Rating Details
2024-10-29 04:17:40 -0500 Rating Details
2024-10-29 04:09:14 -0500 Rating Details
2024-10-29 04:08:06 -0500 Rating Details
2024-10-29 04:04:57 -0500 Rating Details
2024-10-29 04:02:01 -0500 Rating Details
2024-10-29 03:56:43 -0500 Rating Details
2024-10-29 03:54:28 -0500 Rating Details
2024-10-29 20:05:38 -0500 Rating Details
2024-10-29 17:05:45 -0500 Rating Details
2024-10-29 14:50:40 -0500 Rating Details
2024-10-29 08:18:37 -0500 Rating Details
2024-10-29 06:58:08 -0500 Rating Details
2024-10-29 06:12:52 -0500 Rating Details
2024-10-29 05:34:52 -0500 Rating Details
2024-10-29 05:23:36 -0500 Rating Details
2024-10-29 04:49:21 -0500 Rating Details
2024-10-29 04:36:17 -0500 Rating Details
2024-10-29 04:14:12 -0500 Rating Details
2024-10-29 04:06:32 -0500 Rating Details